Results 281 to 290 of about 2,030,203 (332)

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

open access: yesMolecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti   +3 more
wiley   +1 more source

Dynamical networking using Gaussian fields. [PDF]

open access: yesEur Phys J E Soft Matter
du Toit N, Müller-Nedebock KK.
europepmc   +1 more source

Home - About - Disclaimer - Privacy